Silicon Lab Climbs on Deal; Lilly Sees Surging Sales; Chipotle Falls - podcast episode cover

Silicon Lab Climbs on Deal; Lilly Sees Surging Sales; Chipotle Falls

Feb 04, 20265 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

-Silicon Laboratories (SLAB) shares jump as much as 54% to $210.90 in premarket trading after Texas Instruments agreed to acquire the chip designer for $231 per share in cash, in a deal that represents a total enterprise value of approximately $7.5 billion. TXN shares slip 3.4% before the opening bell.

- Eli Lilly (LLY) provided an upbeat sales forecast for the year Wednesday as strong demand for its weight loss drug cemented its position at the top of the obesity market.The guidance was a sharp contrast to rival Novo Nordisk A/S, which warned investors Tuesday that its sales could drop as much as 13% this year on intensifying price competition in the weight loss market. Lilly, on the other hand, expects its sales to grow as much as 27% this year.

- Chipotle Mexican Grill (CMG) doldrums are set to extend into 2026, with the burrito chain offering a full year-sales target that fell short of Wall Street’s expectations.Sales at established locations are expected to be “about flat” this year, Chipotle said in a statement Tuesday. That’s below the average of estimates compiled by Bloomberg and follows a decline in comparable sales in 2025 — the first time that’s happened since Chipotle became a public company.

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, podcasts, radio news. This Stock Movers report your roundup of companies making moves in the stock market, harnessing the power of Bloomberg data.

Speaker 2

Let's take a look at some stocks on the move today to a Lexus Christuffers is out front of Google this afternoon the stock movers right now, Alexis, what do you have.

Speaker 3

I've got Silicon Labs for you. This stock not like when we talk about a lot. The ticket symbol is SLAB. SLAB up fifty percent, just to give you an idea. It's based in Austin. Market cap four and a half billion, one year return last year a snoozer, basically flat. The big news today, Texas Instruments is going to buy Silicon Labs for seven and a half billion dollars. That works to about two hundred and thirty one dollars a share. Transaction expected to close in the first half of next year.

And it looks like Silicon Labs investors like this deal. If you're not familiar with that, Silicon Labs chips are used and everything from smart home devices, industrial automation, battery storage, and commercial lighting. And you know Texas Instruments. I checked I mean, I guess no surprise stock is down about three percent, but last week surprisingly strong sales forecast. I think Texas Instruments is sometimes seen as a barometer, you know, of sorts from much of the economy because of its

outsized role in the global supply chain. So there's your big deal of the day. And I also got to Eli Lilly.

Speaker 4

Just second to guess who advised Silicon Labs from an M and a perspective, Frank Quattrone. Oh my work, cattlest partners still getting it done on silicon.

Speaker 2

Here's to Frank, he and Mike may all worked together a few years ago in Alexis.

Speaker 3

Please all right, Eli Lilly up eight percent, absolutely obliterated. Forecast expects sales to grow as much as twenty seven percent this year. We know it's got those blockbuster weight loss drugs Munjaro zep bound. Sales more than doubled in those drugs year over year, and that's helping give it an edge over rivals like Novo Nordis, which, by the way, I want to mention down five percent said sales are going to drop as much as thirteen percent this year.

If that doesn't underline, you know, price competition in the US. Also, some of its generic versions of its blockbuster drugs are coming to market, so weighing on Eli Lilly there. You know President Trump also made cutting drug costs a key priority of this administration, and we know that Eli Lilly and Novo have both struck deals to offer lower prices as a result. And I want to move over to the food space. Oh yes, now we're talking Chipotelet. I

went there yesterday, a really lovely lunch on Third Avenue. Well, there's going to be very pleased that you said that, because this talk is down five percent today. I don't know about you. I used to go more often. It's been a while. I feel like it's lost its mojo. You know last year, what was it with the food? Prices have gone up and I have noticed that, but also just the for a little while they weren't giving you as much food.

Speaker 4

Well they fixed that in a big way. Yeah, oh my Nay went overboard. Now they overloaded.

Speaker 3

Give me extra chicken. So Chipotle last year's stock down thirty nine percent. They're trying to convince younger consumers, especially because that's really their bread and butter, that there's value there. Right, you got these budget conscious shoppers, where's the value? Also, believe it or not, the weight loss drugs are giving them a problem because people are consuming fewer calories and just higher prices in general. Inflation hitting them as well.

They had that incident a couple of years ago, the rash of food safety concerns that sort of tarnished their image. They had a new CEO at the time. They seem to have bounced back from that, but they can't. They just cannot seem to get the traction they get the foot traffic back into the stores.

Speaker 4

At Child had great lunch there yesterday, High five and those folks breakfast.

Speaker 3

I don't think.

Speaker 2

I just think some of the Pepsi announcement I believe it was yesterday. Yeah, you know, Doritos and Cheetas and the rest. They're going to lower the price, I know. Yeah, I got to believe a Lexus they're going to lower the price but also make the portion smaller.

Speaker 3

Well, that shrink inflation, right, that's why you go and get an MBA exactly.

Speaker 1

Is yeah? Figure that out?

Speaker 2

Yeah, I mean, is that where we are in terms of affordability and purchasing.

Speaker 3

Car Well, it's a sad state of affairs if it is, but I think you're right.

Speaker 1

This stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android